BiotechTube
Home/Nanexa AB/Birgit Stattin Norinder
BS

Birgit Stattin Norinder

Board Member

Nanexa AB

Therapeutic Areas

OncologyMetabolic Disease

Nanexa AB Pipeline

DrugIndicationPhase
NEX-20Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML)Phase I
NEX-18Oncology (Multiple Myeloma)Preclinical
NEX-22Type 2 Diabetes / ObesityDiscovery/Preclinical

Leadership Team at Nanexa AB

DW
David Westberg
Chief Executive Officer (CEO)
CD
Cecilia Danckwardt-Lillieström
Chief Financial Officer (CFO)
MR
Mårten Rooth
Chief Technology Officer (CTO), Co-founder
JH
Joel Hellrup
Head of Pharmaceutical R&D
KB
Kristine Bäck
Director Project Management
AJ
Anders Johansson
Head of Intellectual Property, Co-founder
GA
Göran Ando
Chairman of the Board
RD
Richard Davis
Board Member
JD
Jakob Dynnes Hansen
Board Member
View full Nanexa AB profile